Description: Harbor Biosciences, Inc. (Harbor Biosciences), formerly Harbor Diversified Inc., is a clinical-stage pharmaceutical company. It is engaged in the discovery and development of products for the treatment of diseases that typically onset with age. It is primarily focused on the development of a series of hormone-related sterols that are derived from the human adrenal metabolome. The Company is development-stage company with two product candidates: Apoptone (HE3235) in patients with late-stage prostate cancer, and Triolex (HE3286) in obese type-2 diabetes mellitus patients. The Company focuses on the development of synthetic sterol derivatives derived from the human 19-carbon steroid scaffold of the mammalian sterol metabolome. It has conducted clinical trials with its drug development candidates, which include Apoptone (HE3235); Triolex (HE3286); Neumune (HE2100), for the treatment of sepsis, and HE2000, for the prevention of opportunistic infections in immune-suppressed patients.
Home Page: harbortx.com
W6390 Challenger Drive
Appleton,
WI
54914-9120
United States
Phone:
920 749 4188
Officers
Name | Title |
---|---|
Ms. Christine R. Deister | Pres, CEO, CFO & Sec. |
Mr. Liam S. Mackay | Chief Financial Officer of Air Wisconsin Airlines LLC |
Mr. Robert R. Binns | CEO & Pres of Air Wisconsin Airlines LLC |
Mr. Robert W. Weber | Chief Accounting Officer, VP of Operations & Controller |
Dr. Christopher L. Reading Ph.D. | Chief Scientific Officer |
Mr. Scott A. Rieger | VP of Corp. Communications |
Mr. Robert L. Marsella | Sr. VP of Bus. Devel. & Marketing |
Mr. Gregg Garvey | Sr. VP, Chief Accounting Officer & Treasurer of Air Wisconsin Airlines LLC |
Exchange: PINK
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: | Biotechnology |
Forward PE: | 0 |
---|---|
Trailing PE: | 3.3548 |
Price-to-Book MRQ: | 0.4188 |
Price-to-Sales TTM: | 0.3264 |
IPO Date: | 1995-05-15 |
Fiscal Year End: | December |
Full Time Employees: | 1212 |